Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2008
11/11/2008US7449174 Delivery of analgesics through an inhalation route
11/11/2008US7449173 heating drugs used for the treatment of anxiety or insomnia, coated on solid supports to form vapors and condensing the vapor to form aerosols comprising microstructure particles of the drugs
11/11/2008US7449172 Delivery of antiemetics through an inhalation route
11/11/2008US7449136 Method and apparatus for producing composite particles using supercritical fluid as plasticizing and extracting agent
11/11/2008US7448379 Composition, vessel, dry powder inhalation system, and related methods for transpulmonary administration
11/06/2008WO2008134734A2 Encapsulated contrast agents
11/06/2008WO2008134557A2 Solid dosage forms
11/06/2008WO2008134540A1 Compositions and methods for transmucosal delivery of domperidone
11/06/2008WO2008134512A1 Oral controlled release compositions comprising vitamin d compound and waxy carrier
11/06/2008WO2008134478A2 Increased drug loading capacity of polymeric material
11/06/2008WO2008134071A1 Multimodal abuse resistant extended release formulations
11/06/2008WO2008134047A1 Methods of treating hypertension
11/06/2008WO2008134013A2 Pharmaceutical excipient complex
11/06/2008WO2008133982A2 Adhesive patch with aversive agent
11/06/2008WO2008133952A2 Transmucosal treatment with fentanyl in patients with mucositis
11/06/2008WO2008133928A2 Mucin glycoproteins and their use for treatment of epithelial lesions and mucin dependent disorders
11/06/2008WO2008133908A2 Suspension formulations of insulinotropic peptides and uses thereof
11/06/2008WO2008133901A1 Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
11/06/2008WO2008133731A2 Rapidly disintegrating low friability tablets comprising silica materials
11/06/2008WO2008133704A2 Antimicrobial and antiviral compounds and methods for their use
11/06/2008WO2008133654A2 Method of treating a tumor and biodistribution of a drug delivered by worm-like filomicelles
11/06/2008WO2008133597A1 Method of delivering a protein into a cell
11/06/2008WO2008133537A1 Pharmaceutical composition exhibiting improved stability comprising ace inhibitor or pharmaceutically acceptable salt thereof and method for manufacturing thereof
11/06/2008WO2008133422A1 Method for the preparation of biocompatible polymeric nanoparticles for drug delivery and nanoparticles prepared thereby
11/06/2008WO2008133330A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
11/06/2008WO2008133272A1 Medicated patch
11/06/2008WO2008133157A1 Body-temperature lowering depressant
11/06/2008WO2008133102A1 Novel base for dry solid dispersion, solid dispersion containing the base, and composition containing the dispersion
11/06/2008WO2008132727A2 Oral delivery of proteins and peptides
11/06/2008WO2008132712A2 Combination pharmaceutical compositions
11/06/2008WO2008132710A2 Pharmaceutical nimodipine compositions
11/06/2008WO2008132682A2 Improved vitamin d content uniformity in pharmaceutical dosage forms
11/06/2008WO2008132439A2 Precipitation stabilising compositions
11/06/2008WO2008132274A1 Membrane shell of an implantable dosage system
11/06/2008WO2008132233A1 Composition, methods and kits for prevention of adhesion
11/06/2008WO2008132229A2 Highly concentrated insulin solutions and compositions
11/06/2008WO2008132224A2 Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
11/06/2008WO2008131961A1 Method for the production of adsorbates of a rasagiline salt having a water soluble adjuvant
11/06/2008WO2008131664A1 An agarose gel microsphere and its preparing method
11/06/2008WO2008131506A1 Mucoadhesive granules containing chitosan nano- and/or microspheres and the process of manufacture
11/06/2008WO2008131505A1 Osmotic form for controlled release of active principles
11/06/2008WO2008112722A3 Imatinib mesylate
11/06/2008WO2008111074A3 A method of promoting muscle tissue repair
11/06/2008WO2008104856A3 A synergistic herbal ophthalmic formulation for lowering the intra ocular pressure in case of glaucoma
11/06/2008WO2008102349A3 Terbinafine formulation for iontophoresis
11/06/2008WO2008100375A3 Polymer-based films and drug delivery systems made therefrom
11/06/2008WO2008086176A3 Topical pharmaceutical formulation comprising an inos inhibitor for the treatment of disease
11/06/2008WO2008084312A3 Micronised particles of low-dosage strength active agents for powder formulations for inhalation
11/06/2008WO2008079963A3 Pharmaceutical compositions comprising ionic complexes of active pharmaceutical ingredients
11/06/2008WO2008079543A3 Mesoporous material compositions and methods of their use for improving the appearance of biological surfaces
11/06/2008WO2008070538A3 Micellar nanoparticles comprising botulinum toxin
11/06/2008WO2008070463A3 Endoxifen methods and compositions
11/06/2008WO2008070279A3 Method for precipitation of small medicament particles into use containers
11/06/2008WO2008067037A3 Novel formulations of proton pump inhibitors and methods of using these formulations
11/06/2008WO2008065316A3 Ointment compositions comprising a vitamin d derivative
11/06/2008WO2008061963A3 Helically-shaped drug delivery system
11/06/2008WO2008060365A3 A self-gelling tunable drug delivery system
11/06/2008WO2008055148A3 Semi-solid formulations of phospholipase enzyme inhibitors
11/06/2008WO2008054508A3 Stable nanosized amorphous drug
11/06/2008WO2008046603A3 Adhesive label with bittering agent and fluidifying agents for natural airway secretions
11/06/2008WO2008042216A3 Methods, kits, and compositions for generating new hair follicles and growing hair
11/06/2008WO2008032238A3 Device for automatic adjustment of the dose of melatonin and/or delivery of melatonin
11/06/2008WO2008030462A3 Disposable infusion device with automatic unlocking mechanism
11/06/2008WO2008030361A3 Wake-up on time dietary supplement and method of use
11/06/2008WO2008013785A3 Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
11/06/2008WO2008011169A3 Controlled release formulations and associated methods
11/06/2008WO2008009476A3 Concentrated methotrexate solutions
11/06/2008WO2007150018A3 Steroid-containing sustained release intraocular implants and related methods
11/06/2008WO2007143155A3 Sustained release pharmaceutical dosage form containing phenylephrine
11/06/2008WO2007139744A3 Implantable polymeric device for sustained release of buprenorphine with minimal initial burst
11/06/2008WO2007136663A3 Antibiotic/bone morphogenic protein formulation and method of treatment
11/06/2008WO2007136633A3 Gel-formulations of hydrophobic photosensitizers for mucosal applications
11/06/2008WO2007134120A3 Microfluidic device for forming monodisperse lipoplexes
11/06/2008WO2007128320A3 A pressure sensitive adhesive composition comprising cross-linked polyalkylene oxide and water absorbent hydrophilic agents
11/06/2008WO2007126865A3 Leukotriene antagonists via nasal drug delivery
11/06/2008WO2007124198A3 Biopolymer system for tissue sealing
11/06/2008WO2007106437A3 Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof
11/06/2008WO2007103200A3 Oral controlled release formulation for sedative and hypnotic agents
11/06/2008WO2007009090A3 Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from chitosan and including a polymer mesh material of poly-4-hydroxy butyrate
11/06/2008WO2006046978A3 Cationic peptide-mediated transformation
11/06/2008US20080275684 Treatment protocol generation for diseases related to angiogenesis
11/06/2008US20080275483 Methods and Apparatus for Treating Disorders of the Ear Nose and Throat
11/06/2008US20080275430 Prolonged Transit Time of Permeability-Enhancing Drug Eluting Pill
11/06/2008US20080275409 Wound healing device
11/06/2008US20080275124 Powder of amino acids and method for producing the same
11/06/2008US20080275119 Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN)
11/06/2008US20080275077 Pharmaceutical formulations comprising an immune response modifier
11/06/2008US20080275020 Pharmaceutical formulation
11/06/2008US20080275017 Aromatic sulfenates for type i phototherapy
11/06/2008US20080275013 Mixture of androgen, macrocyclic ketone enhancer and thickener; glandular disorders
11/06/2008US20080275012 Mixture of androgen, such as testosterone, macrocyclic ketone enhancer and thickener; therapy for glandular disorders
11/06/2008US20080275007 Charged phospholipid compositions and methods for their use
11/06/2008US20080275001 Enhanced bioavailability, absorption; using fartty acid, or salt thereof, or fatty ester; sustained release; drug is anticaogulant
11/06/2008US20080274997 Fluid bed granulation process; water soluble grains; solid oral drug
11/06/2008US20080274986 Drug delivery system for accurate fluid dosing onto ingestible medium followed by vehicle evaporation; simplifies manufacturing and distribution; strength variability
11/06/2008US20080274983 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases
11/06/2008US20080274953 Method of Preparing a Protein Aggregate and a Pharmaceutical Preparation
11/06/2008US20080274951 Pharmaceutical compositions including low dosages of desmopressin
11/06/2008US20080274216 Preparation, process and a regenerative method and technique for prevention, treatment and glycemic control of diabetes mellitus
11/06/2008US20080274202 Compositions and Method for Brain Specific Targeted Delivery of Therapeutic Agents
1 ... 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 ... 2991